Stay updated with breaking news from Gene Expression. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A panel of 13 circulating proteins related to the tumor microenvironment may provide prognostic clues to prostate cancer progression.
PHILADELPHIA — (Jan. 17, 2022) — A new study by researchers at The Wistar Institute , an international biomedical research leader in cancer, immunology, infectious disease, and vaccine development, has identified a new potential pathway for developing therapeutics that target Epstein-Barr virus ( EBV ).
Gene Expression Analysis Market analysis report gives a clear idea on various segments that are relied upon to observe the quickest business development amid the estimated forecast frame. This report indicates a professional and all-inclusive study of the market which concentrates on primary and secondary drivers, m...
The Wistar Institute announces the initiation of a Phase 2 clinical study of VK-2019 in patients with advanced Epstein-Barr Virus (EBV)-positive nasopharyngeal carcinoma (NPC) and lymphoma.
/PRNewswire/ -- The Prostate Cancer Foundation (PCF) today announced the Class of 2021 Young Investigator Award recipients totaling nearly $6.5 million in...